Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2014
08/13/2014CN102949415B 一种蜂胶脂肪乳制剂及其制备方法 Propolis fat emulsion and its preparation method
08/13/2014CN102940672B 皂角刺总黄酮在制备预防和治疗肿瘤药物方面的应用 Total flavonoids stings in the preparation of the prevention and treatment of cancer drugs
08/13/2014CN102846794B 治疗癌症的药物组合物及其制备方法 A pharmaceutical composition for treating cancer and its preparation method
08/13/2014CN102846594B 一种异戊烯基黄酮类化合物的药物用途 Drug use an isopentenyl Flavonoids
08/13/2014CN102784397B 用锂皂石粘土纳米颗粒负载阿霉素盐酸盐抗癌药物的方法 With hectorite clay nanoparticles load anticancer drug doxorubicin hydrochloride method
08/13/2014CN102766215B 一种具有协同靶向诊疗鼻咽癌功能的多肽和携带此多肽的纳米颗粒及其应用 Having a synergistic treatment of NPC function targeting peptides and nanoparticles carrying the polypeptide and its application
08/13/2014CN102766184B 原人参二醇过氧化衍生物及其制备方法与应用 Protopanaxadiol too derivative and its preparation method and application oxide
08/13/2014CN102762230B 放射免疫偶联物和其用途 Radioimmunoconjugate and uses thereof
08/13/2014CN102757476B 一种乌贼墨肽聚糖的制备方法和应用 A preparation method and application of sepia peptidoglycan
08/13/2014CN102743469B 牛白藤治疗疾病的新用途 New uses for the treatment of bovine white cane diseases
08/13/2014CN102675401B 抗肿瘤药物lqc-y的制备及其应用 Preparation and Application of antineoplastic lqc-y
08/13/2014CN102660579B HBx和人IL-12双基因重组载体及抗肝癌疫苗 HBx and human IL-12 Double Gene recombinant vector vaccines and anti-hepatoma
08/13/2014CN102633881B 针对her-3的抗体及其用途 For her-3 antibodies and uses thereof
08/13/2014CN102633719B 一种苯胺基取代甲基苯并呋喃喹啉衍生物及其制备方法和应用 One kind of aniline-substituted quinoline derivative methylbenzofuran its preparation method and application
08/13/2014CN102631689B 一种用于诊疗的磁共振成像造影剂及其制备方法 A magnetic resonance imaging contrast agent treatment and preparation methods for
08/13/2014CN102603642B 含镍夹心多金属氧酸盐抗癌药物及其合成方法 Nickel sandwich POMs anticancer drugs and synthetic methods
08/13/2014CN102600065B 一种氟维司群或其衍生物油性制剂及其制备方法 One kind of fulvestrant or a derivative thereof oil and its preparation method
08/13/2014CN102477012B 可抑制人2型11β-羟基类固醇脱氢酶活性的姜黄素类似物的制备及其应用 Inhibit human type 2 11β- hydroxysteroid dehydrogenase activity of preparation and application of curcumin analogues
08/13/2014CN102453701B 基因修饰CDR3δ移植型γδT淋巴细胞及其抑癌用途 Genetically modified CDR3δ transplant type γδT lymphocytes and tumor suppressor use
08/13/2014CN102399233B PI3K和mTOR双重抑制剂类化合物 PI3K and mTOR dual inhibitor compounds
08/13/2014CN102391164B 一种二芳基硫醚化合物、制备方法及其抗肿瘤应用 A two-aryl sulfide compounds, preparation methods and application of anti-tumor
08/13/2014CN102325788B 癌症靶向肽及其在癌症治疗中的用途 Cancer targeting peptides and their use in cancer therapy
08/13/2014CN102321034B 硫代苯二氮卓类化合物及其作为药物的用途 Thiosulfate benzodiazepine class of compounds and their use as medicaments
08/13/2014CN102258772B 一种新的肿瘤树突状细胞治疗性疫苗的制备方法及其用途 A new tumor dendritic cell therapeutic vaccine preparation and use
08/13/2014CN102216292B 四取代的哒嗪hedgehog途径拮抗剂 Tetra-substituted pyridazine hedgehog pathway antagonists
08/13/2014CN102149687B 作为雄激素受体调节剂的咪唑烷化合物 As androgen receptor modulators imidazolidine compounds
08/13/2014CN102137660B 冷薄荷醇受体trpm8的低分子量调节剂的检测和用途 Cold menthol receptor trpm8 low molecular weight modifier and use of detection
08/13/2014CN102083442B 抗氧化剂炎症调节剂：在c-17具有氨基和其它修饰的齐墩果酸衍生物 Oleanolic acid derivatives having an amino group and other modifications in the c-17: Antioxidant Inflammation Modulators
08/13/2014CN102038636B 一种含有螯合剂的紫杉烷类药物溶液及其制备方法 A chelating agent is a taxane-containing solution and a preparation method
08/13/2014CN101928344B 抗cd20的人单克隆抗体 The human monoclonal antibody anti-cd20
08/13/2014CN101888780B 喹诺酮类似物及其相关方法 Quinolone analogs and related methods
08/13/2014CN101861151B 使用组蛋白脱乙酰基酶hdac1、hdac2和/或hdac3的选择性抑制剂和微管稳定剂的癌症组合治疗 The use of histone deacetylase hdac1, hdac2 and cancer combination therapy / or hdac3 selective inhibitors and microtubule stabilizer
08/13/2014CN101796073B 针对cxcr3的人源化抗体 For the humanized antibody cxcr3
08/13/2014CN101747354B 一类β氨基酸组成的二肽硼酸及其酯类化合物、制备方法及其用途 Dipeptide boronic acid and its esters for a class of β amino acid composition, preparation and uses
08/13/2014CN101698852B 具有cd137l功能的蛋白或多肽及其基因和应用 Protein or polypeptide and gene functions and applications with cd137l
08/13/2014CN101175760B 雷帕霉素的39-去甲氧基衍生物 Rapamycin 39- to methoxy derivative
08/12/2014US8802837 Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer
08/12/2014US8802725 Transition metal complexes of a bis[thiohydrazine amide] compound
08/12/2014US8802717 Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
08/12/2014US8802703 Arylamino N-heteraryl compounds as MEK inhibitors
08/12/2014US8802667 Benzodiazepine derivatives
08/12/2014US8802397 Method of producing the polypeptide for treating virus-induced cancer
08/12/2014US8802138 Methods and compositions for improved deliver, expression or activity of RNA interference agents
08/12/2014US8802093 HER2/neu-specific antibodies and methods of using same
08/12/2014CA2807787C Hmb compositions and uses thereof
08/12/2014CA2755266C Intermediates for preparing macrocyclic analogs
08/12/2014CA2726040C Quinazoline derivatives
08/12/2014CA2551813C Compositions and methods for the treatment of tumor of hematopoietic origin
08/12/2014CA2497644C Whole bacterial cells as immune modulator
08/12/2014CA2482893C Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
08/07/2014WO2014121062A1 Selective hdac3 inhibitors
08/07/2014WO2014120683A1 Small-molecule inhibitors targeting g-protein-coupled rho guanine nucleotide exchange factors
08/07/2014WO2014120654A1 Benzoquinolone inhibitors of vmat2
08/07/2014WO2014118807A1 A novel process for the preparation of sorafenib tosylate form iii
08/07/2014WO2014118785A1 Generation of cytotoxic tumor specific cell lines and uses thereof
08/07/2014WO2014118740A1 Macrocyclic lactone derivatives and uses thereof
08/07/2014WO2014118578A1 Composition comprising a tnfr agonist and at least one thioredoxin inhibitor for use in the treatment of carcinoma.
08/07/2014WO2014118438A1 Composition for binding aldehydes in the mouth
08/07/2014WO2014118229A1 Substituted thienopyrimidines and pharmaceutical use thereof
08/07/2014WO2014118226A1 Substituted pyrazolopyrimidinylamino-indazoles
08/07/2014WO2014118186A1 Amino-substituted isothiazoles
08/07/2014WO2014118135A1 Amidoimidazopyridazines as mknk-1 kinase inhibitors
08/07/2014WO2014118039A1 Radiolabeled compounds
08/07/2014WO2014117919A1 Positive allosteric modulators of mglur3
08/07/2014WO2014117741A1 Heterocyclo compounds as apoptotic inducers and uses thereof
08/07/2014WO2014117710A1 Commands and method of treating cancer via rho pathway
08/07/2014WO2014117272A1 Spermidine/spermine n1-acetyltransferase antibodies as anti-cancer drug compounds
08/07/2014WO2014060493A3 N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
08/07/2014WO2014060375A3 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
08/07/2014WO2013049600A8 Compositions for rf ablation
08/07/2014US20140221381 Thienopyrimidine compounds and use thereof
08/07/2014US20140220676 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220113 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220109 Novel cochleate formulations
08/07/2014US20140220013 Method for the diagnosis and prognosis of malignant diseases
08/07/2014DE102010039019B4 Antikörper gegen 6-sulfo LacNAc positive humane dendritische Zellen und deren Verwendung Antibodies against 6-sulfo LacNAc positive human dendritic cells and their use
08/06/2014EP2762489A1 Glycosylated polypeptide and pharmaceutical composition containing same
08/06/2014EP2762476A1 1,2,4-triazine-6-carboxamide derivative
08/06/2014EP2762475A1 Pharmaceutically acceptable salts of quinolinone compounds and their medical use
08/06/2014EP2762472A2 Selenophene-fused aromatic compound and manufacturing method thereof
08/06/2014EP2762469A1 Crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate, crystal of 5-hydroxy-1h-imidazole-4-carboxamide 3/4 hydrate, and method for producing same
08/06/2014EP2762166A1 Antigen-binding molecule for promoting loss of antigens
08/06/2014EP2762165A2 Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
08/06/2014EP2762149A2 Erythropoietin-derived peptide and use therefor
08/06/2014EP2762148A1 Novel phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition
08/06/2014EP2762145A1 Sodium meta arsenite for use in the treatment of pain and/or inflammation associated with cancer
08/06/2014EP2762142A1 Compositions for treating cancer
08/06/2014EP2762140A1 Treatment of solid brain tumours with a rapamycin derivative
08/06/2014EP2760891A1 Hybrid constant regions
08/06/2014EP2760870A1 Substituted bicyclic heteroaryl compounds
08/06/2014EP2760867A1 Macrocyclic flt3 kinase inhibitors
08/06/2014EP2760865A2 Novel heterocyclic derivatives and their uses
08/06/2014EP2760860A2 Nitrogen mustard derivatives
08/06/2014EP2760857A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
08/06/2014EP2760854A1 Imidazole derivatives as cyp17 inhibitors for the treatment of cancer
08/06/2014EP2760842A1 An improved process for the preparation of bendamustine hydrochloride
08/06/2014EP2760841A1 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
08/06/2014EP2760826A1 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
08/06/2014EP2760823A1 Novel compounds as hif-1alpha inhibitors and manufacturing process thereof
08/06/2014EP2760820A2 Sphingosine analogs, compositions, and methods related thereto
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 2211